Clinical Trial Update: D-cycloserine for Relapse Prevention Following Intravenous Ketamine in Treatment-resistant Depression [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating D-cycloserine for relapse prevention after intravenous ketamine treatment in treatment-resistant depression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Treatment-resistant Depression

Drugs mentioned

• D-cycloserine (D-cycloserine)
• Ketamine (ketamine)

Snippet

Sponsor: Sheba Medical Center | Conditions: Treatment Resistant Depression | Phase 4 | Status: UNKNOWN